MedTrace Logo

Depiction of Prostate Cancer Treatment Alternatives in Greece

NCT00733213 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 310

Last updated 2009-10-14

No results posted yet for this study

Summary

A retrospective, registry analysis of the socio-economic and demographic characteristics of patients suffering from locally advanced or metastatic prostate cancer, as well as the depiction of the therapeutic algorithms followed in the Greek clinical practice.

* Target Group: Patients with locally advanced or metastatic prostate cancer.
* The first 10 consecutive patients records that meet the entry criteria.

Conditions

  • Locally Advanced or Metastatic Prostate Cancer.

Sponsors & Collaborators

Principal Investigators

  • Panagiotis Pontikis, MD · AstraZeneca Greece

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Completion
2009-03-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00733213 on ClinicalTrials.gov